Evaluate the Safety Profile of BGF MDI in Chinese Patients With COPD in Routine Clinical Practice

Clinical trial NCT04536402 · COMPLETED

Trial details

NCT number: NCT04536402
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2021-03-16
Primary completion: 2023-11-08
Enrollment: 3520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.